Sapyen has launched an at-home male fertility testing kit in the United Kingdom. The Australia-based company allows men to collect a sample at home and send it to a laboratory for analysis.
The test uses Sapyen’s SPX72 medium, which preserves sperm viability for up to 72 hours during transit. Results are delivered within days. The test is priced starting at $149 and provides semen analysis and advanced assays including DNA fragmentation and DNA methylation.
Research shows that in current IVF practice, a significant number of men are not tested at the outset, with women often undergoing procedures first. One in four men in IVF are never tested, according to Sapyen.
“The NHS is running fertility care on a playbook written decades ago,” said Olivia Musa, scientist and founder of The Male Fertility Clinic. “Men are sent across the country for the simplest test, then told to wait months or years. By then, couples have already spent thousands and women have shouldered procedures they may never have needed. It’s not just delay, it’s damage.”
“One in four men in IVF are never tested. That is not an oversight; it is a systemic flaw that keeps repeating,” said Ash Ramachandran, CEO of Sapyen. “Women are sent into £10,000 cycles of hormones and procedures before the man is even tested. The order is wrong, the costs are enormous, and the impact on families is devastating. Sapyen puts the first step back where it belongs: test the man quickly, at home, and give couples clarity within days.”
The at-home test is available to order online across the UK. Samples are analyzed at CLIA-certified partner laboratories. Sapyen was founded to make sperm testing accessible and data-driven through its patent-pending preservation technology.
